Chemotherapy for one type of leukaemia could be improved by giving patients a drug currently used in the treatment of iron overload new research has showed. Acute myeloid leukaemia (AML) is an aggressive cancer that stops healthy blood cell production. Chemotherapy is the standard treatment but improvements are needed as the five-year survival rate in patients older than 60 is only 5-15 per cent. The findings from Imperial College London showed that special regions of blood vessels where blood stem cells -- that generate billions of new cells every day of our life -- reside are the hardest hit by
